The store will not work correctly when cookies are disabled.
(2R)-2-Amino-4-methylsulfonyl-N-[3-(trifluoromethoxy)phenyl]butanamide
ID: ALA4744809
PubChem CID: 155289362
Max Phase: Preclinical
Molecular Formula: C12H15F3N2O4S
Molecular Weight: 340.32
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CS(=O)(=O)CC[C@@H](N)C(=O)Nc1cccc(OC(F)(F)F)c1
Standard InChI: InChI=1S/C12H15F3N2O4S/c1-22(19,20)6-5-10(16)11(18)17-8-3-2-4-9(7-8)21-12(13,14)15/h2-4,7,10H,5-6,16H2,1H3,(H,17,18)/t10-/m1/s1
Standard InChI Key: SJCAGVRRCBPLMJ-SNVBAGLBSA-N
Molfile:
RDKit 2D
22 22 0 0 0 0 0 0 0 0999 V2000
15.4936 -8.4980 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.6764 -8.4980 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.0850 -9.2057 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.8437 -5.2333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8426 -6.0528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5506 -6.4618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2603 -6.0524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2575 -5.2297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5488 -4.8244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1346 -6.4609 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.4272 -6.0517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7191 -6.4597 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.4278 -5.2345 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.7155 -5.6419 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.9686 -6.4598 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6757 -6.0501 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3841 -6.4576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6744 -5.2329 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0911 -6.0479 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.3853 -7.2748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6783 -7.6845 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9725 -8.9114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
5 10 1 0
10 11 1 0
11 12 1 0
11 13 1 0
11 14 1 0
7 15 1 0
15 16 1 0
16 17 1 0
16 18 2 0
17 19 1 6
17 20 1 0
20 21 1 0
21 2 1 0
2 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 340.32 | Molecular Weight (Monoisotopic): 340.0705 | AlogP: 1.29 | #Rotatable Bonds: 6 |
Polar Surface Area: 98.49 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.97 | CX Basic pKa: 7.44 | CX LogP: 0.67 | CX LogD: 0.35 |
Aromatic Rings: 1 | Heavy Atoms: 22 | QED Weighted: 0.81 | Np Likeness Score: -1.26 |
References
1. Yamada Y,Takashima H,Walmsley DL,Ushiyama F,Matsuda Y,Kanazawa H,Yamaguchi-Sasaki T,Tanaka-Yamamoto N,Yamagishi J,Kurimoto-Tsuruta R,Ogata Y,Ohtake N,Angove H,Baker L,Harris R,Macias A,Robertson A,Surgenor A,Watanabe H,Nakano K,Mima M,Iwamoto K,Okada A,Takata I,Hitaka K,Tanaka A,Fujita K,Sugiyama H,Hubbard RE. (2020) Fragment-Based Discovery of Novel Non-Hydroxamate LpxC Inhibitors with Antibacterial Activity., 63 (23): [PMID:33210531] [10.1021/acs.jmedchem.0c01215] |